Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.
Influenza Medication Market contains market size and forecasts of Influenza Medication in global, including the following market information:
- Global Influenza Medication Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Influenza Medication Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Influenza Medication companies in 2021 (%)
The global Influenza Medication market was valued at 545.7 million in 2021 and is projected to reach US$ 750.9 million by 2028, at a CAGR of 4.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Zanamivir Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Influenza Medication include Daiichi Sankyo Company, GlaxoSmithKline, Natco Pharma, F. Hoffmann-La Roche, Teva Pharmaceutical, Sandoz International, Sun Pharmaceutical Industries and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Influenza Medication manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Influenza Medication Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Influenza Medication Market Segment Percentages, by Type, 2021 (%)
- Zanamivir
- Oseltamivir
- Peramivir
- Amantadine
- Rimantadine
- Inosine
- Others
Global Influenza Medication Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Influenza Medication Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Pharmacies
- Others
Global Influenza Medication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Influenza Medication Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Influenza Medication revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Influenza Medication revenues share in global market, 2021 (%)
- Key companies Influenza Medication sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Influenza Medication sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Daiichi Sankyo Company
- GlaxoSmithKline
- Natco Pharma
- F. Hoffmann-La Roche
- Teva Pharmaceutical
- Sandoz International
- Sun Pharmaceutical Industries
- Mylan
Industry Market Size
